NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Voyageur Pharmaceuticals Ltd (V: VM)
VM Technical Analysis
5
As on 1st May 2025 VM SHARE Price closed @ 0.19 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.06 & Strong Buy for SHORT-TERM with Stoploss of 0.06 we also expect STOCK to react on Following IMPORTANT LEVELS. |
VMSHARE Price
Open | 0.19 | Change | Price | % |
High | 0.19 | 1 Day | 0.00 | 0.00 |
Low | 0.18 | 1 Week | 0.04 | 26.67 |
Close | 0.19 | 1 Month | 0.04 | 26.67 |
Volume | 229650 | 1 Year | 0.15 | 375.00 |
52 Week High 0.24 | 52 Week Low 0.04 |
V Canada Most Active Stocks
SML | 1435.70 | 0.53% |
NU | 10.36 | -26.32% |
GXU | 0.05 | 0.00% |
SNS | 0.40 | -2.44% |
SIE | 0.02 | 0.00% |
AEC | 0.06 | 0.00% |
AL | 0.04 | 33.33% |
PGM | 0.02 | 0.00% |
FLT | 0.13 | -7.14% |
QPM | 0.04 | 0.00% |
V Canada Top Gainers Stocks
V Canada Top Losers Stocks
VM Daily Charts |
VM Intraday Charts |
Whats New @ Bazaartrend |
VM Free Analysis |
|
VM Important Levels Intraday
RESISTANCE | 0.21 |
RESISTANCE | 0.20 |
RESISTANCE | 0.20 |
RESISTANCE | 0.20 |
SUPPORT | 0.18 |
SUPPORT | 0.18 |
SUPPORT | 0.18 |
SUPPORT | 0.17 |
VM Forecast May 2025
4th UP Forecast | 0.23 |
3rd UP Forecast | 0.22 |
2nd UP Forecast | 0.21 |
1st UP Forecast | 0.2 |
1st DOWN Forecast | 0.18 |
2nd DOWN Forecast | 0.17 |
3rd DOWN Forecast | 0.16 |
4th DOWN Forecast | 0.15 |
VM Weekly Forecast
4th UP Forecast | 0.19 |
3rd UP Forecast | 0.19 |
2nd UP Forecast | 0.19 |
1st UP Forecast | 0.19 |
1st DOWN Forecast | 0.19 |
2nd DOWN Forecast | 0.19 |
3rd DOWN Forecast | 0.19 |
4th DOWN Forecast | 0.19 |
VM Forecast2025
4th UP Forecast | 0.58 |
3rd UP Forecast | 0.45 |
2nd UP Forecast | 0.38 |
1st UP Forecast | 0.3 |
1st DOWN Forecast | 0.08 |
2nd DOWN Forecast | 0 |
3rd DOWN Forecast | -0.07 |
4th DOWN Forecast | -0.2 |
Voyageur Pharmaceuticals Ltd ( V Canada Symbol : VM )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
VM Other Details
Segment | EQ | |
Market Capital | 10075200.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
VM Address
![]() |
VM Latest News
VM Business Profile
Voyageur Pharmaceuticals Ltd. focuses on the development of active pharmaceutical ingredients minerals. The company intends to develop barium and iodine radiocontrast products and bromine based pharmaceutical products. It holds 100% interest in three barium sulfate deposits, including two properties suitable in grade for the pharmaceutical barite marketplace located in British Columbia, Canada; and interests in a high-grade iodine, lithium, and bromine brine project in Utah, the United States. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. is headquartered in Calgary, Canada. Address: 339?50th Avenue SE, Calgary, AB, Canada, T2G 2B3
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service